U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07693426) titled 'Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents' on June 29.
Brief Summary: This is a Phase Ib, randomized, double-blind, placebo-controlled clinical study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of Efsubaglutide Alfa Injection following multiple-dose administration in Chinese adolescent participants with obesity.
Study Start Date: July 10
Study Type: INTERVENTIONAL
Condition:
Adolescence Obesity
Intervention:
DRUG: Efsubaglutide Alfa 5 mg QW
Efsubaglutide Alfa Injection Subcutaneous injection
DRUG: Efsubaglutide Alfa 10 mg QW
Efsubaglutide Alfa Injection Su...